1.
The TCM Literature Study of Syndrome and Therapeutic Principles Research on Alcoholic Hepatic Fibrosis (Jiu Pi);
酒精性肝纤维化（酒癖）的中医文献研究
2.
Mechanism of Tiaogan Lipi prescription on alcohol hepatic fibrosis
调肝理脾方抗酒精性肝纤维化作用机制研究
3.
Experimental research on inhibiting action of Tiaoganlipi prescription on alcohol hepatic fibrosis
调肝理脾方抑制酒精性肝纤维化的实验研究
4.
Establishment of Mouse Model of Alcoholic Liver Fibrosis and Clinical Analysis of Alcoholic Liver Disease;
小鼠酒精性肝纤维化模型的建立及酒精性肝病的临床分析
5.
Studies on the Characteristics of Traditional Chinese Medical Syndrome of Alcoholic Liver Fibrorosis and on the Molecular Mechanisms of Manganxiao Compound Anti-Fibrorosis;
酒精性肝纤维化中医证候特点和慢肝消抗酒精性肝纤维化的分子机制
6.
Effect of Chondroitin Sulfate on Liver Fibrosis Induced by Alcohol in Mice;
硫酸软骨素对大鼠酒精性肝纤维化模型的影响
7.
Distribution Research on the Clinical Data of 199 Cases with Alcoholic Fibrosis
199例酒精性肝纤维化临床资料分布研究
8.
Studies on the Syndrome Classification of Alcoholic Liver Fibrosis in TCM and on the Mechanisms of Tiaoganlipi Formula Anti-Fibrorosis;
酒精性肝纤维化中医证候学和调肝理脾方作用机理研究
9.
Experimental Study on Alcoholic Liver Fibrosis by FFBJRGP;
复方鳖甲软肝片治疗酒精性肝纤维化的实验研究
10.
Study on the Mechanisms of Regulating Collagen Degradation in Rat Alcoholic Liver Fibrosis with Man-Gan-Xiao;
慢肝消调控酒精性肝纤维化大鼠胶原降解的机制研究
11.
Study on Mechanism of Compound Biejiaruangan Troche in Inhibiting Alcohol Hepatic Fibrosis in Rats
复方鳖甲软肝片抑制大鼠酒精性肝纤维化作用机制研究
12.
Study on the Correlation of TCM Syndrom Characteristics Distribution of Alcoholic Hepatic Fibrosis
酒精性肝纤维化中医证候特点分布的相关性研究
13.
The Relationship between DDR2 and Alcoholic Liver Fibrosis and Intervention Therapeutic Effect of Compound Glycyrrhizin Tablets;
DDR2与酒精性肝纤维化的关系及复方甘草酸苷的干预和治疗作用
14.
Clinical Observation of "Qinggan Huayu Decoction" in Treating Hepatic Fibrosis Following Nonalcoholic Fatty Liver Diseases
清肝化瘀方抗非酒精性脂肪性肝炎肝纤维化疗效观察
15.
Successive Observationg of Sinusoid Capillarization during the Formation of Non-alcoholic Fatty Liver Fibrosis in Rabbit;
家兔非酒精性脂肪肝肝纤维化形成中肝窦毛细血管化的变化
16.
Preventive Effects of JieJiuFuFang Against Liver Fibrosis of Rats with Alcoholic Fatty Liver and the Involving Mechanisms;
解酒复方对酒精性脂肪肝大鼠肝纤维化的预防作用及机制
17.
The Effect of Telmisartan on Hepatic Fibrosis in Nonalcoholic Steatohepatitis Rat Model
替米沙坦对非酒精性脂肪性肝炎模型大鼠肝纤维化的影响
18.
Observation on Changes of Serum Liver Fibrosis Markers Levels in Patients with NASH
非酒精性脂肪性肝炎患者血清肝纤维化指标观察